MDxHealth SA Stock Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
Sales 2023 | 64.39M 69.08M | Sales 2024 * | 73.53M 78.88M | Capitalization | 63.43M 68.05M |
---|---|---|---|---|---|
Net income 2023 | -39M -41.84M | Net income 2024 * | -26M -27.89M | EV / Sales 2023 | 1.51 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.86 x |
P/E ratio 2023 |
-2.37
x | P/E ratio 2024 * |
-2.46
x | Employees | 255 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 97.37% |
Latest transcript on MDxHealth SA
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |